MaryEapenMD
Pediatric Hematology & Oncology • Milwaukee, WIAssociate Professor, Medicine, Medical College of Wisconsin
Are you Dr. Eapen?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 32 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
9000 W Wisconsin Ave
Division Of Pediatric Hematology/Oncology
Milwaukee, WI 53226Phone+1 414-456-4170Fax+1 414-456-6543
Summary
- Dr. Mary Eapen, MD is a pediatric hematologist/oncologist in Milwaukee, Wisconsin. She is currently licensed to practice medicine in Wisconsin and Minnesota. She is affiliated with Froedtert and the Medical College of Wisconsin Froedtert Hospital and Children's Wisconsin.
Education & Training
University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1997 - 2000- University of MinnesotaResidency, Pediatrics, 1995 - 1997
Ahmadu Bello UniversityClass of 1986
Certifications & Licensure
WI State Medical License 2000 - 2025
MN State Medical License 1998 - 2020- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503) Start of enrollment: 2016 Nov 01
Publications & Presentations
PubMed
- Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study.Mary Eapen, Joseph H Antin, Jakub Tolar, Sally Arai, Mitchell E Horwitz
Eclinicalmedicine. 2024-10-01 - Immunosuppression with post-transplant cyclophosphamide for allogeneic hematopoietic cell transplantation.Mary Eapen
Haematologica. 2024-07-01 - Navigating Treatment Options and Communication in Relapsed Pediatric AML.Zachary Graff, Franziska Wachter, Mary Eapen, Leslie Lehmann, Todd Cooper
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2024-06-01
Press Mentions
Researchers Develop a Validated Pediatric Disease Risk Index for AML and ALLFebruary 1st, 2021- Navigating Treatment Options and Communication in Relapsed Pediatric AMLJune 17th, 2024
